ABSTRACT
Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory disorder that frequently presents as a mass lesion, can involve a wide range of extranodal sites, and is often accompanied by lymphadenopathy. The diagnosis of IgG4-RD involves correlation of clinical findings with characteristic pathologic features, including a lymphoplasmacytic infiltrate with a preponderance of IgG4+ plasma cells, storiform fibrosis, and obliterative phlebitis. 1 Increased numbers of IgG4+ plasma cells are often encountered in reactive lymph nodes of patients with IgG4-RD, termed IgG4-related lymphadenopathy, 2 as well as in nodal and extranodal sites in association with various neoplastic and inflammatory processes other than IgG4-RD. 1 For example, increased IgG4+ plasma cells have been reported in patients with multicentric Castleman disease, 3 rheumatoid arthritis, 4 Rosai-Dorfman disease, 5 and other chronic inflammatory diseases. 6, 7 Increased numbers of IgG4+ plasma cells can also be seen in the background of some neoplasms. 1 As in IgG4-RD, the IgG4+ plasma cells found in IgG4-related lymphadenopathy and in the background of other inflammatory or neoplastic processes are polyclonal.
The identification of a monotypic IgG4+ plasmacytic population, on the other hand, should prompt diagnostic consideration of a B-cell lymphoma or plasma cell neoplasm. Recent reports of lymphomas occurring in patients with IgG4-RD, [8] [9] [10] [11] [12] [13] [14] [15] along with the characterization of IgG4+ lymphomas and plasma cell neoplasms with distinct clinicopathologic features, 19, 20 Indeed, recent studies implicate clonally expanded CD4+ cytotoxic T lymphocyte cytokine production in the development of fibrosis and pathogenesis of IgG4-RD. 20 However, no definitive link between IgG4-RD and hematolymphoid neoplasia has been identified, and a morphologically identifiable lesion bridging the gap between IgG4-RD and lymphoma or a plasma cell neoplasm has not been described. Further characterization of clonal IgG4+ proliferations, including those occurring in the setting of IgG4-RD, is needed. Therefore, we set out to report the clinicopathologic features of a series of atypical IgG4+ plasmacytic proliferations with evidence of clonality.
Materials and Methods
This study was approved by the institutional review board of Massachusetts General Hospital/Partners Healthcare. Cases containing atypical IgG4+ plasmacytic proliferations were identified from the hospital pathology files (cases 1 and 2) through a natural language search of the pathology database using the terms IgG4 and clonal, monotypic, or monoclonal or from the consultation files of two authors (J.A.F. and V.D.) (cases 3-11). Case 5 was included in a prior study on IgG4-related orbital disease. 21 Clonality or oligoclonality was based on the demonstration of a monotypic population of IgG4+ plasma cells through immunohistochemistry or in situ hybridization for immunoglobulin light chains, with or without the demonstration of a clonal IGH gene rearrangement by polymerase chain reaction (PCR). H&E-stained and immunostained slides were prepared at Massachusetts General Hospital and/or at the referring institution. Immunostains performed at Massachusetts General Hospital were performed on 5-μm formalin or B-plus-fixed, paraffin-embedded sections using an automated immunostainer (BOND-III; Leica Microsystems, Bannockburn, IL). Briefly, sections were deparaffinized, and antigen retrieval was performed with an EDTA-based solution at pH 9 or a citrate-based solution at pH 6. Sections were stained for IgG (clone RWP49, dilution 1:800; Cell Marque, Rocklin, CA), IgG4 (clone IGHG4, dilution 1:25; Cell Marque), and κ (clone CH15, dilution 1:1,000; Leica Microsystems) and λ (clone SHL53, dilution 1:7,000; Leica Microsystems) immunoglobulin light chains and, in selected cases, CD20 (clone L26, dilution 1:100; Leica Microsystems), CD3 (clone LN10, ready to use [RTU]; Leica Microsystems), BCL6 (clone LN22, RTU; Leica Microsystems), BCL2 (clone bcl2/100/D5, RTU; Leica Microsystems), CD138
(clone B-A38, dilution 1:400; Cell Marque), HHV8 (clone 13B10, dilution 1:100; Leica Microsystems), and/ or EBER (cat. ISH5687a, RTU, pretreatment enzyme for 15 minutes; Leica Microsystems). Flow cytometry was performed on internal cases (cases 1 and 2) using a BD FACSCanto II flow cytometer and BD FACSDiva software (BD Biosciences, San Jose, CA), as well as BD Biosciences fluorochrome-conjugated antibodies. PCR for IGH gene rearrangement was performed using primers that hybridize to conserved framework (regions 1, 2, and 3) and joining regions of the immunoglobulin heavy chain gene (InVivoScribe Technologies, BIOMED, San Diego, CA) and PCR products analyzed through capillary gel electrophoresis. Variable immunohistochemical, flow cytometric, and molecular studies were performed by the referring institutions prior to the time of consultation in cases 3 to 11. Clinical data were limited in some consultation cases.
The diagnosis of lymphoma or a plasma cell neoplasm was rendered according to the criteria of the World Health Organization 2008 classification. 22 Mean IgG4 plasma cell counts were based on the average number of IgG4+ plasma cells in the three high-power fields (hpf) with the most IgG4+ plasma cells. The diagnosis of ❚Image 1❚ Case 3: a 40-year-old man with left groin lymphadenopathy. The lymph node was enlarged with reactive follicles separated by bands of fibrosis (A). Many follicles contained increased plasma cells (B), including atypical forms with enlarged or lobated nuclei (C). The intrafollicular plasma cells expressed immunoglobulin G4 (IgG4) (D).
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AJCP / Original article IgG4-related sclerosing sialadenitis of the right submandibular gland rendered in case 4 was based on the consensus histopathologic criteria for IgG4-RD, including the presence of storiform fibrosis, a dense lymphoplasmacytic infiltrate with a mean of more than 100 IgG4+ plasma cells per hpf, and an IgG4/IgG plasma cell ratio of more than 40%. 
Results
We identified 11 cases of IgG4+ plasmacytic proliferations. These included five cases (cases 1-5) with monotypic IgG4+ plasma cells that did not meet diagnostic criteria for a lymphoma or plasma cell neoplasm, designated here as atypical IgG4+ plasmacytic proliferations. The remaining six cases (cases 6-11) fulfilled criteria for the diagnosis of lymphoma or a plasma cell neoplasm.
Summary of Clinical Features at Presentation
Patients included six men and five women. The median age at the time of diagnosis was 68 years (range, 40-94 years) for all cases, 67 years (range, 40-80 years) for atypical IgG4+ plasmacytic proliferations, and 77 years (range, 57-94 years) for IgG4+ lymphoid and plasma cell neoplasms. Patients had lymphadenopathy (n = 5), a gradually enlarging extranodal mass (n = 4), or both (n = 2). The extranodal masses were identified in the orbit (three cases), the submandibular gland (two cases), and the parotid gland. Four patients carried previous diagnoses of autoimmune conditions, including immune thrombocytopenic purpura, Hashimoto thyroiditis, and rheumatoid arthritis. One patient had both Evans syndrome and myasthenia gravis. Four patients had histories of atopy, including asthma, allergies, and eczema. One patient (case 7) had received prednisone and rituximab for Evans syndrome, and one (case 11) had received longterm methotrexate for rheumatoid arthritis. There was no known history of immunosuppression in the other cases. Clinical features and follow-up data are listed in ❚Table 1❚.
Atypical IgG4+ Plasmacytic Proliferations
The pathologic features of the atypical IgG4+ plasmacytic proliferations are detailed in ❚Table 2❚. Lymph node excisions from cases 1 to 3 shared morphologic features, including reactive follicular hyperplasia with many monotypic IgG4+ plasma cells within germinal centers, usually confined to a subset of lymphoid follicles ❚Image 1❚. Follicle lysis was observed in cases 1 and 3, interfollicular plasmacytoid dendritic cell aggregates in case 1, and progressive transformation of germinal centers and focal fibrosis in case 3. Polytypic plasma cells were also present in some follicles in case 1 and in an interfollicular distribution in case 3. In case 3, the monotypic IgG4+ plasma cells demonstrated cytologic atypia with enlarged and multilobated nuclei (Image 1). In case 1, the patient developed recurrent lymphadenopathy in the opposite axilla after 2.7 years with morphologic features similar ❚Image 1❚ (cont) Most follicles showed a marked excess of IgG4+ κ-restricted plasma cells (E, κ) in comparison to λ (F, λ). A few follicles showed excess IgG4+ λ-restricted plasma cells (not shown). A, ×20; D, ×40; E, F, ×100; B, ×400; C, ×1,000.
to the initial specimen, including persistent monotypic IgG4+ intrafollicular plasma cells (see Table 2 .)
In case 4 ❚Image 2❚, the submandibular mass showed findings consistent with IgG4-related sclerosing sialadenitis, including a dense lymphoplasmacytic infiltrate with germinal center formation, maintenance of the normal lobular architecture, septal and focal storiform fibrosis, and increased (>100/hpf) extrafollicular polytypic IgG4+ plasma cells. However, some germinal centers also contained numerous monotypic IgG4+ plasma cells (>100/ hpf in some follicles), including many with cytoplasmic inclusions of immunoglobulin (Mott cells). The patient developed IgG4-related pancreatitis 10 months later, consistent with IgG4-RD.
Case 5 ❚Image 3❚ was an upper eyelid mass composed of a nodular lymphohistiocytic infiltrate, including reactive follicles, many xanthogranulomatous histiocytes, and frequent eosinophils. There were regions with increased (>100/hpf) IgG4+ plasma cells with a marked excess of κ expression (κ/λ ratio of ~10:1). Thick bands of fibrosis were present surrounding the infiltrate. A clonal IGH gene rearrangement was present by PCR. Although some features raised the possibility of mucosa-associated lymphoid tissue (MALT) lymphoma, the mixed infiltrate and ❚Image 2❚ Case 4: a 67-year-old woman with a right submandibular mass composed of a nodular lymphoplasmacytic infiltrate separated by bands of fibrosis (A) with regions of storiform fibrosis with many plasma cells (B). The inflammatory infiltrate included scattered reactive follicles and frequent plasma cells in both interfollicular regions and within the follicles (C). Most of both inter-and intrafollicular plasma cells were immunoglobulin G4+ (IgG4+) (D; inset, immunoglobulin G).
© American Society for Clinical Pathology
AJCP / Original article lack of a diffuse B-cell or plasma cell proliferation precluded a definitive diagnosis of lymphoma or a plasma cell neoplasm.
Although follow-up was limited in these five cases of atypical IgG4+ plasma cell proliferations, at a median follow-up of 24 months (range, 3 months to 3 years), no patient had developed lymphoma or a plasma cell neoplasm.
IgG4+ Lymphomas and Plasma Cell Neoplasms
The pathologic features of six cases meeting criteria for an IgG4+ lymphoma or plasma cell neoplasm are detailed in ❚Table 3❚.
Case 6 ❚Image 4❚ was an enlarged lymph node from an 87-year-old man that showed interfollicular expansion by monotypic IgG4+ Mott cells admixed with small lymphocytes, scattered mature-appearing plasma cells, and rare eosinophils. Background normal-appearing plasma cells were polytypic and mostly negative for IgG4. Residual follicles included some with involuted germinal centers and "hyaline-vascular"-type changes. PCR for IGH gene rearrangement showed a prominent peak in a polyclonal background. The findings were most consistent with either a B-cell lymphoma with marked plasmacytic differentiation or a nodal plasmacytoma.
Case 7 ❚Image 5❚ was that of a 57-year-old woman with a complicated medical history (see Table 1 ) who had a parotid mass and mediastinal lymphadenopathy.
Excision demonstrated an intraparotid lymph node with follicular and paracortical hyperplasia, numerous monotypic intra-and interfollicular IgG4+ λ+ Mott cells, and scattered background typical-appearing polytypic plasma cells. PCR was negative for a clonal IGH gene rearrangement. The findings were considered insufficient for a diagnosis of lymphoma. A mediastinal lymph node biopsy 2.4 months later showed an IgG4+ small B-cell lymphoma with marked plasmacytic differentiation, including frequent IgG4+ λ+ Mott cells. The changes in the parotid lymph node were retrospectively interpreted as partial involvement by lymphoma. Of note, the patient carried a prior diagnosis of nodal marginal zone lymphoma from 7 years earlier with κ-restricted B cells and without significant plasmacytic differentiation or Mott cells, which was considered unrelated to the more recent lymphoma.
Case 8 was that of an 85-year-old man who had an orbital mass and bilateral neck lymphadenopathy. The orbital mass ❚Image 6A❚, ❚Image 6B❚, ❚Image 6C❚, ❚Image 6D❚, and ❚Image 6E❚ contained a dense lymphoplasmacytic infiltrate with monotypic λ-restricted IgG4+ plasma cells and B cells consistent with MALT lymphoma. MYD88 L265 mutational analysis was negative. Excision of a neck mass (Image 6E) ❚Image 6F❚, ❚Image 6G❚, ❚Image 6H❚, and ❚Image 6I❚ 1.5 months later showed a lymph node and salivary gland tissue with sclerosis, frequent aggregates (>100/hpf) of mature-appearing plasma cells, and no Mott cells (Image 6). Immunohistochemistry showed discrete regions with abundant κ-restricted or λ-restricted ❚Image 2❚ (cont) There was a marked excess of IgG4+ κ-restricted plasma cells in follicles, whereas interfollicular plasma cells were polytypic (E, κ; F, λ). A, whole mount; B, D (and inset), E, F, ×100; C, ×400. plasma cells, all of which expressed IgG4 (Image 6). No clonal B-cell population was identified by flow cytometry or PCR. The histologic features were suspicious for IgG4-related chronic sclerosing sialadenitis, but the density of the infiltrate and immunophenotypic evidence of light chain restriction were atypical for IgG4-RD. The findings in the neck mass were considered those of an atypical IgG4+ plasmacytic proliferation.
In case 9 ❚Image 7❚, an axillary lymph node excision from a 68-year-old man showed replacement by plasma cells, including some with cytoplasmic immunoglobulin inclusions, scattered eosinophils, and histiocytes, including some with emperipolesis. There were frequent IgG4+ plasma cells (mean, 96/hpf and 31% of IgG+ plasma cells) with a marked excess of κ light chain expression. S100 stained histiocytes, including those with emperipolesis. PCR identified a clonal IGH gene rearrangement. The findings were interpreted as an unusual plasma cell neoplasm associated with changes suspicious for Rosai-Dorfman disease.
Cases 10 and 11 were submandibular and orbital masses containing a nodular proliferation of CD20+ B cells and ❚Image 3❚ Case 5: a 73-year-old man with a right upper eyelid mass with a dense lymphoplasmacytic and histiocytic infiltrate and bands of fibrosis (A). The inflammatory infiltrate contained scattered reactive follicles with surrounding mixed inflammation, including many small lymphocytes, plasma cells, histiocytes, and eosinophils (B). Plasma cells were predominantly immunoglobulin G4+ (IgG4+) (C; D, immunoglobulin G) with a marked excess of κ-restricted plasma cells (κ/λ ratio of 10:1; not shown). A, C, D, ×100; B, ×200. monotypic IgG4+ plasma cells, consistent with MALT lymphoma. Frequent Mott cells were present in case 10, both within the infiltrate and within surrounding reactive follicles. Background irregular and band-like fibrosis was present in both cases, raising the possibility of underlying IgG4-RD. However, the frequent monotypic IgG4+ plasma cells hampered identification of a background increase in polytypic IgG4+ plasma cells as would be expected in IgG4-RD.
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Discussion
We describe 11 cases of unusual IgG4+ plasmacytic proliferations. These include a group of five cases of clonal IgG4+ plasma cell proliferations that were not diagnostic of a conventional lymphoma or plasma cell neoplasm (atypical IgG4+ plasmacytic proliferations) and a group of six cases felt to be diagnostic of neoplasia (IgG4+ lymphoma or plasma cell neoplasm). In the former group, the clonal IgG4+ plasma cells often occurred within a distinct anatomic compartment in the background of a reactive lymphoid proliferation (such as within reactive germinal centers). In contrast, the cases considered diagnostic for a conventional neoplasm demonstrated destructive growth with obliteration of normal nodal or extranodal architecture.
Despite the heterogeneity of the cases in this series, there were a number of common features in case 1 suggest that such findings may occur in the background of reactive inflammatory or autoimmune disorders. As also noted in case 1, the monotypic IgG4+ proliferations and related lymphadenopathy may persist for several years.
In case 4, the intrafollicular proliferation of monotypic IgG4+ plasma cells was similar to cases 1 to 3 but occurred in the background of IgG4-related sclerosing sialadenitis. Several prior reports have also documented the occurrence of lymphomas or monotypic IgG4+ plasma cell populations in IgG4-RD. [24] [25] [26] Go et al 27 described a series of ocular adnexal IgG4-RD that included two such cases, the first interpreted as an IgG4+ MALT lymphoma in a background of IgG4-RD. The second case from that series demonstrated light chain restriction of IgG4+ plasma cells but neither a clonal IGH gene rearrangement nor the monomorphic growth characteristic of lymphoma. 27 The latter case may represent an atypical IgG4+ plasmacytic proliferation akin to cases 1 to 5 described in the current series.
Despite the rare reports of clonal IgG4+ proliferations occurring in IgG4-RD, the relationship of IgG4-RD to the development of the clonal IgG4+ proliferations is uncertain. A recent study demonstrated the emergence of oligoclonal somatically hypermutated IgG4+ plasmablastic populations in IgG4-RD, supportive of clonal expansion driven by immunologic response to a specific antigen. 19 Following treatment with rituximab, new plasmablast clones with distinct V-J rearrangements emerged, supporting the reactive nature of these clones. 19 Similarly the lack of monomorphic or destructive growth by the monotypic plasma cell proliferation in case 4 suggests that the process may be reactive in nature rather than neoplastic. However, identification of any clonal plasma cell or B-cell process should necessarily prompt further clinical workup to exclude malignancy.
The second group of cases described in this study included IgG4+ lymphomas or plasma cell neoplasms. Previously reported IgG4+ lymphomas and plasma cell neoplasms appear to have clinical features similar to their non-IgG4-expressing counterparts. For example, IgG4+ plasma cell myelomas were clinically similar to non-IgG4-producing myeloma, other than a higher predisposition to necrotizing fasciitis. 16 Similarly, meningeal IgG4+ MALT lymphomas behaved similar to the IgG4-group. 17 In these prior reports, as in cases 6 to 11 of the current series, underlying IgG4-RD was not present in any case, suggesting that most IgG4+ lymphoid and plasma cell neoplasms are unrelated to IgG4-RD.
Some morphologic features of IgG4+ lymphoid and plasmacytic neoplasms may be relatively unique. For example, IgG4+ myelomas showed an increased rate of plasmablastic morphology, 16 and one of six cases of IgG4+ meningeal MALT lymphoma showed numerous Mott cells. Similarly, the high frequency of Mott cells in the IgG4+ neoplasms in our series is, in our experience, quite uncommon in other lymphomas ❚Image 4❚ (cont) inset, immunoglobulin G) and were κ-restricted (E) with few background small λ+ plasma cells (F). A prominent IGH gene rearrangement was present in a polyclonal background. The overall findings were considered consistent with an IgG4+ B-cell lymphoma with marked plasmacytic differentiation or a plasma cell neoplasm. A, ×40; C, E, F, ×100; D (and inset), ×200; B, ×400.
and plasma cell neoplasms. Although the number of reported cases is small, such atypical morphologic features may be related to distinctive biology of IgG4-producing neoplasms.
Cases 7 and 8 are particularly interesting given the distinct pathologic findings on sequential biopsy specimens. Case 7 initially presented with partial lymph node involvement by an IgG4+ lymphoma with similar morphology to the atypical IgG4+ proliferations in cases 1 to 5 of this series. This case underscores the fact that further clinical workup is necessary when a monotypic IgG4+ plasma cell population is identified. In specimen 2 from case 8, the presence of two distinct monotypic IgG4+ plasma cell proliferations and a background of fibrosis were suggestive of IgG4-related sclerosing sialadenitis with an oligoclonal expansion of IgG4+ plasma cells. Although the relationship between this process and the orbital IgG4+ lymphoma diagnosed 1.5 months earlier is uncertain, this case raises the possibility of evolution from IgG4-RD to an oligoclonal IgG4+ plasma cell proliferation and subsequently to overt IgG4+ B-cell lymphoma.
❚Image 5❚ Case 7: a 57-year-old woman with a history of nodal marginal zone lymphoma with an interfollicular proliferation of marginal zone-type B cells (A; inset, CD20), 7 years prior to presentation with an enlarged parotid lymph node. The parotid lymph node contained a proliferation of atypical Mott cells within and between follicles (B, C; C inset, high power). The Mott cells were positive for immunoglobulin G (D) and immunoglobulin G4 (IgG4) (D inset) and were λ-restricted. ❚Image 5❚ (cont) (E, λ; F, κ). Scattered background small polytypic plasma cells were present with strong expression of light chains and were also present in follicles. Biopsy specimen of a mediastinal lymph node 2 months later showed an identical Mott cell infiltrate (G) admixed with frequent CD20+ B cells (H). The Mott cells expressed IgG4 (I) and were λ-restricted (I inset). The overall findings were consistent with an IgG4+ B-cell lymphoma with marked plasmacytic differentiation. B, ×40; A (and inset), D-F, H, ×100; C, G, I (and inset), ×200; D inset, ×400; C inset, ×1,000.
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The cases in this series overlap morphologically with IgG4-RD and IgG4-related lymphadenopathy. Prior studies have also described IgG4+ lymphomas or plasma cell neoplasms that may mimic IgG4-RD. 16, 17, 28 Distinction of a lymphomatous process from IgG4-RD or another reactive proliferation requires determination of clonality, and stains for immunoglobulin light chains may be useful when considering the diagnosis of IgG4-RD. The presence of storiform fibrosis and/or obliterative phlebitis that characterize IgG4-RD would be uncommon in lymphoma or a plasma cell neoplasm. Similarly, determining whether underlying IgG4-RD is present in cases of IgG4+ lymphoma or plasma cell neoplasms may be difficult or impossible since the clonal IgG4+ cells may mask the underlying polytypic IgG4+ plasma cells that characterize IgG4-RD. 9 Serum IgG4, although widely thought of as a marker for IgG4-related disease, is not specific for that entity. 29 Elevations of serum IgG4 may be also seen in IgG4+ neoplasms without evidence of underlying IgG4-RD, 16 although in such ❚Image 6❚ (cont) (E). The infiltrate was composed of scattered reactive follicles and frequent small mature-appearing plasma cells with no Mott cells (F). Nearly all plasma cells expressed IgG4 (G; G inset, IgG). In some regions, the IgG4+ plasma cells appeared κ-restricted (H), while in other regions they appeared λ-restricted (I), consistent with an oligoclonal expansion of IgG4+ plasma cells. A, ×20; E, ×40; G (and inset), H, I, ×100; C (and inset), D (and inset), F, ×200; B, ×400.
AJCP / Original article cases there may be an associated M-component by serum protein electrophoresis. In summary, we describe a series of clonal IgG4+ plasmacytic proliferations that can be broadly split into two categories: those diagnostic for lymphoma or a plasma cell neoplasm and those present in the background of a reactive lymphoid proliferation, designated here as atypical IgG4+ plasmacytic proliferations. We detail the clinicopathologic features of the atypical IgG4+ plasmacytic proliferations, which have not been well characterized previously. Many of the clonal IgG4+ plasma cell proliferations in this series have distinct morphologic features, including prominent Mott cells and/or preferential localization to follicles in the atypical IgG4+ plasmacytic proliferations. Such features may be useful clues to recognizing the presence of a clonal IgG4+ plasma cell process. Finally, our data and prior studies show that clonal IgG4+ plasma cell proliferations may occur rarely in IgG4-RD, whereas most IgG4+ lymphomas and plasma cell neoplasms are unrelated to IgG4-RD. These cases raise questions about the development of monotypic IgG4+ plasmacytic proliferations in reactive conditions and IgG4-RD, as well as about the ❚Image 7❚ Case 9: a 68-year-old man with extensive lymphadenopathy. Excision of an axillary lymph node showed effacement by a diffuse mixed inflammatory cell infiltrate, including frequent plasma cells, histiocytes, and eosinophils, as well as some plasma cells with cytoplasmic immunoglobulin inclusions (A, B). Immunoglobulin G4+ (IgG4+) plasma cells were increased (C; C inset, immunoglobulin G) with a marked excess of κ expression (D; D inset, λ). IgG4, immunoglobulin G4. a Only cases in which IGH gene rearrangement studies were performed on the diagnostic neoplastic tissue are included. In case 6, there was a prominent IGH rearrangement in a polyclonal background, supportive a diagnosis of a B-lineage neoplasm. In cases 7 and 8, the analysis was only performed on prior or subsequent specimens.
